Loading provider…
Loading provider…
Medical Oncology Physician in Cortlandt Manor, NY
NPI: 1295833937Primary Practice Location
HUDSON VALLEY HOSPITAL CENTER
1980 Crompond Rd, Cortlandt Manor, NY
Primary Employer
Option Care
optioncarehealth.com
HQ Phone
Get MD Mark's Phone Numberphone_androidMobile
Get MD Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Zucker School of Medicine at Hofstra/Northwell
Residency • Internal Medicine
1975 - 1978
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 85 | 418 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 46 | 107 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 36 | 137 |
| 4 | 36415Insertion of needle into vein for collection of blood sample | 35 | 241 |
Characteristics and outcomes of lung cancer in solid organ transplant recipients.
Authors: Selim Arcasoy, Bryan Stanifer, William Bulman, Luke Benvenuto, Lanyi Chen, Matthen Mathew, Naiyer Rizvi, Catherine Shu
Journal: Lung Cancer
Publication Date: 2020-06-20
Authors: William Bulman, Naiyer Rizvi, Catherine Shu, Joshua Sonett
Journal: Cancer Cytopathol
Publication Date: 2017-10-12
Comparative effects of intravenously administered alizapride and prochlorperazine in cisplatin-induced emesis.
Authors: Roché, H., Hyman, G., Nahas, G., Stoopler, M., Ellison, R., Desjardins, R.
Lead Sponsor: Columbia University
Collaborators: Genentech, Inc., Celgene Corporation
Intervention / Treatment: DRUG: Carboplatin, DRUG: Nab-paclitaxel, DRUG: MPDL3280A
Lead Sponsor: Columbia University
Collaborators: Merck Sharp & Dohme LLC, National Cancer Institute (NCI), Massachusetts General Hospital
Intervention / Treatment: DRUG: Carboplatin, DRUG: Pembrolizumab, DRUG: Nab-paclitaxel, DRUG: Pemetrexed